About Us
MANAGEMENT
- Asher Wilf – Founder & CEO
- Ph.D Sergey Bujanover – Chief Scientist & CTO
SCIENTIFIC ADVISORY BOARD
- Prof. Alexander Sulakvelidze – Phage Microbiology – UOM
- Prof. Steve Abedon – Phage Molecular Biology & Ecology – OSU
- Prof. Natalia Voroshilova – Phage Production and Phage Therapy
- Prof. Gerald Cohen – Molecular Biology – TAU
- Prof. Alik Honigman – Molecular Biology – HUJI
- Prof. Ethan Rubinstein – Infectious Disease – UManitoba
- Prof. Zeev Handzel – Immunology – Kaplan
CONSULTANTS
- Business Development – Vered Levy-Ron
- Legal – Adv./CPA Elroy Knebel and Adv.Aaron Kaufman
- Patent Attorneys – Webb & Co.
- Regulatory Affairs: Hebetim – Riva Gur Arie-Sharon & Anat Averbuch
- Financial – CPA Shuki Geva
Intro
• Bacteriophages (“Phages”) are viruses that can only attach to, replicate in, and in the process, kill specific bacteria by lysis
• Phages are estimated to be the most abundant and the most diverse entities in the biosphere and constitute a primary force of nature decimating the bacterial mass by half every 48 hours
• Phages are isolated, concentrated and applied in specific niches in order to eradicate specific bacteria
• Phages thrive in the presence of bacteria, and die out in their absence
• Phages action is specific, and does not harm vital micro flora
• Phages may be used both preventively, and in the treatment of ongoing infections
• Phages present the only viable alternative and the last resort for the treatment of antibiotic-resistant infections
• Phage-bacteria co-evolution provides for an inexhaustible reservoir of phages
